Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia. The company's drug discovery platform Magellan discovers novel allosteric binding sites in a...
11 insider purchases on record · latest filing 2024-08-12.
Insiders have also filed 2 sale transactions at GANX.